EASTMAN CHEMICAL CO
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $8.8B | $9.4B | $9.2B | $10.6B | $10.5B |
| Cost of revenue | $6.9B | $7.1B | $7.1B | $8.4B | $8.0B |
| Gross profit | $1.8B | $2.3B | $2.1B | $2.1B | $2.5B |
| Selling, general & administrative | $658.0M | $736.0M | $727.0M | $726.0M | $795.0M |
| Research and development | $255.0M | $250.0M | $239.0M | $264.0M | $254.0M |
| Pretax income | $568.0M | $1.1B | $1.1B | $977.0M | $1.1B |
| Income tax expense | $93.0M | $170.0M | $191.0M | $181.0M | $215.0M |
| Net income | $474.0M | $905.0M | $894.0M | $793.0M | $857.0M |
| Balance Sheet | |||||
| Cash and equivalents | $566.0M | $837.0M | $548.0M | $493.0M | $459.0M |
| Current assets | $3.6B | $4.1B | $3.5B | $3.8B | $4.6B |
| Total assets | $14.9B | $15.2B | $14.6B | $14.7B | $15.5B |
| Current liabilities | $2.7B | $2.7B | $2.6B | $3.3B | $3.0B |
| Total liabilities | $8.8B | $9.4B | $9.1B | $9.4B | $9.7B |
| Total debt | $4.8B | $5.0B | $4.8B | $5.2B | $5.2B |
| Stockholders' equity | $6.0B | $5.8B | $5.5B | $5.2B | $5.7B |
| Cash Flow Statement | |||||
| Cash from operations | $970.0M | $1.3B | $1.4B | $975.0M | $1.6B |
| Depreciation and amortization | $513.0M | $509.0M | $498.0M | $477.0M | $538.0M |
| Stock-based compensation | $48.0M | $63.0M | $64.0M | $69.0M | $70.0M |
| Capital expenditure | $546.0M | $599.0M | $828.0M | $611.0M | $555.0M |
| Free cash flow | $424.0M | $688.0M | $546.0M | $364.0M | $1.1B |
| Dividends paid | $381.0M | $379.0M | $376.0M | $381.0M | $375.0M |
| Share repurchases | $100.0M | $300.0M | $150.0M | $1.1B | $900.0M |
| Impairments | $33.0M | $5.0M | $0 | $0 | $16.0M |
Shares outstanding 114.3M · Free float 97.4%
Annual filing data through FY ended December 31, 2025; float as of July 11, 2026.